๐ค ๐๐ ๐ข๐ฌ ๐๐๐๐จ๐ฆ๐ข๐ง๐ ๐ฉ๐๐ซ๐ญ ๐จ๐ ๐จ๐ฎ๐ซ ๐๐ฏ๐๐ซ๐ฒ๐๐๐ฒ ๐ฅ๐ข๐ฏ๐๐ฌ, ๐๐ฎ๐ญ ๐ก๐จ๐ฐ ๐๐จ ๐ฐ๐ ๐๐ง๐ฌ๐ฎ๐ซ๐ ๐ข๐ญ ๐ญ๐ซ๐ฎ๐ฅ๐ฒ ๐ฌ๐๐ซ๐ฏ๐๐ฌ ๐๐ง๐ข๐ฆ๐๐ฅ ๐ก๐๐๐ฅ๐ญ๐ก?
From personal tools to professional decision-making, AI is now everywhere.
In animal health, it holds real promise, if used with science, ethics and responsibility.
On 14 January 2026, European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) jointly published a landmark set of common principles for good AI practice in medicine development: a strong signal for the entire health ecosystem.
๐๐ ๐ฉ๐ซ๐ข๐ง๐๐ข๐ฉ๐ฅ๐๐ฌ ๐ญ๐จ ๐ค๐๐๐ฉ ๐๐ ๐๐ฅ๐ข๐ ๐ง๐๐ ๐ฐ๐ข๐ญ๐ก ๐ฌ๐๐ข๐๐ง๐๐ & ๐๐ญ๐ก๐ข๐๐ฌ:
๐ง Human-centric and ethically grounded by design
โ๏ธ Risk-based approach adapted to context of use
๐ Compliance with scientific, quality and regulatory standards (GxP)
๐ฏ Clear definition of purpose and scope
๐ฅ Multidisciplinary expertise (AI, medical, regulatory, quality)
๐๏ธ Robust data governance, traceability and documentation
๐ ๏ธ Transparent, explainable and robust model design
๐ Performance assessed based on real-world risk
๐ Continuous lifecycle monitoring and improvement
๐ฃ๏ธ Clear, accessible information for users and stakeholders
๐พ ๐๐๐ค๐-๐ก๐จ๐ฆ๐ ๐ฆ๐๐ฌ๐ฌ๐๐ ๐
AI can accelerate progress in animal health. Used responsibly, it can strengthen evidence, support better decisions and create sustainable value for animals, veterinarians and companies alike.
๐ Read the EMAโFDA announcement:
https://lnkd.in/gwTjWhvU